Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503761 - 503780 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,20ML | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,20ML | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,4ML | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,4ML | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC12) brodalumab (adm: P) | SILIQ 210MG/1.5ML INJ,SYR,1.5ML | 2X1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BauschHealthUS,LLC |
| USA | (L04AC12) brodalumab (adm: P) | SILIQ 210MG/1.5ML INJ,SYR,1.5ML | 2X1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BauschHealthUS,LLC |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA INDUCTION 100MG/ML INJ,PEN,2ML | 2X2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,2M | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,2M | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
Pages
